Timothy Eugene Sullivan sold $1.2M of Apellis Pharmaceuticals (APLS)

Executed Sep 8 2025, disclosed Sep 10 2025, 2 days later.

Value, as filed

$1.2M

42,729 sh across 2 lots

Executed

Sep 8 2025

the trade date, as filed

Disclosed

Sep 10 2025

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

TS Timothy Eugene Sullivan Chief Financial Officer profile →

Timothy Eugene Sullivan (Chief Financial Officer) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in APLS. The largest single filing was $280K of APLS (10,000 sh × $28.03, as filed), executed Oct 21 2025.

The name

APLS APLS APLS · 32 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Timothy Eugene Sullivan in APLS

APLSSALE Apellis Pharmaceuticals, Inc. $224K
10,287 sh × $21.77
Exec Jan 22
Filed Jan 23 · 5:30 PM ET APLSSALE Apellis Pharmaceuticals, Inc. $280K
10,000 sh × $28.03
Exec Oct 21 2025
Filed Oct 23 2025 · 5:30 PM ET